CCL22 and neoplasm: Similar to gliomas, several non-CNS tumors, including ovarian (76), breast (77), prostate (78), gastric (79), esophageal (80), as well as Hodgkin lymphoma (81) tumor cells can also elaborate CCL22 to help recruit Tregs into the tumor microenvironment.